831 related articles for article (PubMed ID: 28529319)
1. Therapeutic targeting of the angiopoietin-TIE pathway.
Saharinen P; Eklund L; Alitalo K
Nat Rev Drug Discov; 2017 Sep; 16(9):635-661. PubMed ID: 28529319
[TBL] [Abstract][Full Text] [Related]
2. How do angiopoietins Tie in with vascular endothelial growth factors?
Saharinen P; Bry M; Alitalo K
Curr Opin Hematol; 2010 May; 17(3):198-205. PubMed ID: 20375888
[TBL] [Abstract][Full Text] [Related]
3. VEGF and angiopoietin signaling in tumor angiogenesis and metastasis.
Saharinen P; Eklund L; Pulkki K; Bono P; Alitalo K
Trends Mol Med; 2011 Jul; 17(7):347-62. PubMed ID: 21481637
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin inhibitors: A review on targeting tumor angiogenesis.
Parmar D; Apte M
Eur J Pharmacol; 2021 May; 899():174021. PubMed ID: 33741382
[TBL] [Abstract][Full Text] [Related]
5. Insight into the Role of Angiopoietins in Ageing-Associated Diseases.
Hayashi SI; Rakugi H; Morishita R
Cells; 2020 Dec; 9(12):. PubMed ID: 33302426
[TBL] [Abstract][Full Text] [Related]
6. Targeting Angiopoietin in Retinal Vascular Diseases: A Literature Review and Summary of Clinical Trials Involving Faricimab.
Khan M; Aziz AA; Shafi NA; Abbas T; Khanani AM
Cells; 2020 Aug; 9(8):. PubMed ID: 32785136
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders.
Akwii RG; Mikelis CM
Drugs; 2021 Oct; 81(15):1731-1749. PubMed ID: 34586603
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietins in angiogenesis.
Fagiani E; Christofori G
Cancer Lett; 2013 Jan; 328(1):18-26. PubMed ID: 22922303
[TBL] [Abstract][Full Text] [Related]
9. Regulation of endometrial vascular remodelling: role of the vascular endothelial growth factor family and the angiopoietin-TIE signalling system.
Girling JE; Rogers PA
Reproduction; 2009 Dec; 138(6):883-93. PubMed ID: 19755482
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems.
Eklund L; Kangas J; Saharinen P
Clin Sci (Lond); 2017 Jan; 131(1):87-103. PubMed ID: 27941161
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data.
Joussen AM; Ricci F; Paris LP; Korn C; Quezada-Ruiz C; Zarbin M
Eye (Lond); 2021 May; 35(5):1305-1316. PubMed ID: 33564135
[TBL] [Abstract][Full Text] [Related]
12. Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease.
Hussain RM; Neiweem AE; Kansara V; Harris A; Ciulla TA
Expert Opin Investig Drugs; 2019 Oct; 28(10):861-869. PubMed ID: 31513439
[No Abstract] [Full Text] [Related]
13. [Advances of Angiopoietin-Tie axis in vascular and lymphatic system-related diseases].
Wang R; Huang M; Xu Y; Yuan C; Huang M; Jiang L
Sheng Wu Gong Cheng Xue Bao; 2021 Aug; 37(8):2633-2644. PubMed ID: 34472284
[TBL] [Abstract][Full Text] [Related]
14. Connection of pericyte-angiopoietin-Tie-2 system in diabetic retinopathy: friend or foe?
Cai J; Ruan Q; Chen ZJ; Han S
Future Med Chem; 2012 Nov; 4(17):2163-76. PubMed ID: 23190105
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietin: a TIE(d) balance in tumor angiogenesis.
Shim WS; Ho IA; Wong PE
Mol Cancer Res; 2007 Jul; 5(7):655-65. PubMed ID: 17634421
[TBL] [Abstract][Full Text] [Related]
16. Targeting the angiopoietin/Tie2 pathway: cutting tumor vessels with a double-edged sword?
Cascone T; Heymach JV
J Clin Oncol; 2012 Feb; 30(4):441-4. PubMed ID: 22184396
[No Abstract] [Full Text] [Related]
17. The emerging role of the Angiopoietin-Tie pathway as therapeutic target for treating retinal diseases.
Ferro Desideri L; Traverso CE; Nicolò M
Expert Opin Ther Targets; 2022 Feb; 26(2):145-154. PubMed ID: 35098845
[TBL] [Abstract][Full Text] [Related]
18. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
19. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
20. Tie-1: A potential target for anti-angiogenesis therapy.
Yang P; Chen N; Jia JH; Gao XJ; Li SH; Cai J; Wang Z
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):615-622. PubMed ID: 26489611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
